Author | Suresh S. Ramalingam, MD | OncLive

Author | Suresh S. Ramalingam, MD

Articles

Dr. Ramalingam on the OS Results of the FLAURA Trial in EGFR-Mutant NSCLC

September 28, 2019

Video

Suresh S. Ramalingam, MD, discusses the overall survival (OS) results of the phase III FLAURA trial in patients with EGFR-mutant non–small cell lung cancer (NSCLC).

Dr. Ramalingam on the Activity of Osimertinib Combinations in NSCLC

September 06, 2019

Video

Suresh S. Ramalingam, MD, deputy director, Winship Cancer Institute of Emory University, discusses the activity of osimertinib (Tagrisso) in combination with other agents in EGFR-mutant non–small cell lung cancer (NSCLC).

Dr. Ramalingam on the Use of Osimertinib in Clinical Trial and Real-World Settings

April 24, 2019

Video

Suresh S. Ramalingam, MD, deputy director, Winship Cancer Institute of Emory University, discusses the impact of osimertinib (Tagrisso) in both clinical trial and real-world settings.

Dr. Ramalingam on Avelumab Plus Lorlatinib in NSCLC

June 23, 2018

Video

Suresh S. Ramalingam, MD, deputy director, Winship Cancer Institute of Emory University, discusses the combination of avelumab (Bavencio) plus lorlatinib in patients with non–small cell lung cancer.

x